Wellgistics Health signs LOI to evaluate USD 105 million acquisition of Neuritek Therapeutics

Reuters03-23
Wellgistics Health signs LOI to evaluate USD 105 million acquisition of Neuritek <a href="https://laohu8.com/S/LENZ">Therapeutics</a>
  • Wellgistics entered a non-exclusive, non-binding letter of intent to evaluate a potential acquisition of Neuritek Therapeutics.
  • The proposed transaction is an all-stock deal with an indicated value of USD 105.0 million.
  • The potential acquisition remains subject to due diligence, definitive agreements, and board approvals.
  • The scope, structure, and terms of any deal may change during negotiations.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wellgistics Health Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202603230905ACCESSWRNAPR_____1150528) on March 23, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment